Clinical Trial Results: Multi-modal Assessment of Gamma-aminobutyric Acid (GABA) Function in Psychosis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing GABA function in psychosis across schizophrenia and bipolar disorder; results completed and posted in 2026.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Schizophrenia

Snippet

Sponsor: University of Michigan | Conditions: Schizophrenia, Bipolar Disorder | Phase 4 | Status: COMPLETED | Results posted: 2026-06-17